Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)

Stopped early

Conditions studied: Cannabis Use, Drug Use, Development, Infant

In brief

The overall objective of this proposed project is to prospectively evaluate the epigenetic and developmental effects of paternal cannabis and other drug use in offspring.

Key facts

Study ID

NCT04436055

Run by

Duke University

People needed

92

Starts

2020-10-26

Expected to finish

2022-07-01

Last updated by the study team

2023-03-03

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Both mother and father are between 18 and 40 years of age
• Free from significant medical conditions, as determined by medical history and examination from attending Obstetrician or health care provider.
• Father is able to be contacted and consents to provide urine and sperm samples
• Both mother and father consent to participation and for the prospective enrollment of their child after birth
• Plan on delivering their baby at one of the two main Duke-affiliated hospitals (Duke University Medical Center and Duke Regional Hospital)

You may not qualify if…

• Mother or Father currently prescribed any psychoactive medication;
• Mother or Father unable to comply with study requirements or otherwise unsuitable for participation in the opinion of the PI.

Where it is running

• Duke Child and Family Study Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.